28 related articles for article (PubMed ID: 26558470)
1. Ochratoxin A-induced cytotoxicity, genotoxicity and reactive oxygen species in kidney cells: An integrative approach of complementary endpoints.
Costa JG; Saraiva N; Guerreiro PS; Louro H; Silva MJ; Miranda JP; Castro M; Batinic-Haberle I; Fernandes AS; Oliveira NG
Food Chem Toxicol; 2016 Jan; 87():65-76. PubMed ID: 26627377
[TBL] [Abstract][Full Text] [Related]
2. The Functions of Cytochrome P450 ω-hydroxylases and the Associated Eicosanoids in Inflammation-Related Diseases.
Ni KD; Liu JY
Front Pharmacol; 2021; 12():716801. PubMed ID: 34594219
[TBL] [Abstract][Full Text] [Related]
3. Involvement of cytochrome P450 enzymes in inflammation and cancer: a review.
Stipp MC; Acco A
Cancer Chemother Pharmacol; 2021 Mar; 87(3):295-309. PubMed ID: 33112969
[TBL] [Abstract][Full Text] [Related]
4. Alteration of CYP4A11 expression in renal cell carcinoma: diagnostic and prognostic implications.
Kim S; Kim JM; Lee HJ; Lim JS; Seong IO; Kim KH
J Cancer; 2020; 11(6):1478-1485. PubMed ID: 32047554
[No Abstract] [Full Text] [Related]
5. Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic Target.
Elshenawy OH; Shoieb SM; Mohamed A; El-Kadi AO
Pharmaceutics; 2017 Feb; 9(1):. PubMed ID: 28230738
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 eicosanoids in hypertension and renal disease.
Fan F; Muroya Y; Roman RJ
Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):37-46. PubMed ID: 25427230
[TBL] [Abstract][Full Text] [Related]
7. 20-HETE and blood pressure regulation: clinical implications.
Wu CC; Gupta T; Garcia V; Ding Y; Schwartzman ML
Cardiol Rev; 2014; 22(1):1-12. PubMed ID: 23584425
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on adriamycin-induced toxicity of human renal tubular epithelial cell (HK-2).
Tian T; Li J; Wang MY; Xie XF; Li QX
Eur J Pharmacol; 2012 May; 683(1-3):246-51. PubMed ID: 22421401
[TBL] [Abstract][Full Text] [Related]
9. Regulation of CYP2E1 by ethanol and palmitic acid and CYP4A11 by clofibrate in primary cultures of human hepatocytes.
Raucy JL; Lasker J; Ozaki K; Zoleta V
Toxicol Sci; 2004 Jun; 79(2):233-41. PubMed ID: 15056802
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of 10 CYP4A11 allelic variants to evaluate the effect of genotype on arachidonic acid ω-hydroxylation.
Saito T; Honda M; Takahashi M; Tsukada C; Ito M; Katono Y; Hosono H; Saigusa D; Suzuki N; Tomioka Y; Hirasawa N; Hiratsuka M
Drug Metab Pharmacokinet; 2015 Feb; 30(1):119-22. PubMed ID: 25760539
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11.
Powell PK; Wolf I; Jin R; Lasker JM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1327-36. PubMed ID: 9618440
[TBL] [Abstract][Full Text] [Related]
12. Distribution of cytochrome P-450 4A and 4F isoforms along the nephron in mice.
Stec DE; Flasch A; Roman RJ; White JA
Am J Physiol Renal Physiol; 2003 Jan; 284(1):F95-102. PubMed ID: 12388424
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin-mediated cytotoxicity through inducing CYP4A 11 expression in human renal tubular epithelial cells.
Li J; Li D; Tie C; Wu J; Wu Q; Li Q
J Toxicol Sci; 2015 Dec; 40(6):895-900. PubMed ID: 26558470
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
